Please login to the form below
bevacizumab
This page shows the latest bevacizumab news and features for those working in and with pharma, biotech and healthcare.
Pfizer's 2021 revenue predictions soar to $82bn
Pfizer’s biosimilars business grew by 34% to $575m, driven by the launches of Ruxience (rituximab), Zirabev (bevacizumab) and Trazimera (trastuzumab), as well as continued growth from Retacrit (epoetin) in the
Latest news
-
Merck receives first breast cancer approval in Europe for Keytruda
or without bevacizumab based on data from the phase 3 KEYNOTE-826 trial.
-
Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars
These savings derived mainly from trastuzumab and bevacizumab to treat a range of cancers, infliximab for autoimmune diseases, and pegfilgrastim to treat chemotherapy-related neutropenia, says the report.
-
FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
cancer, two-thirds of which had previously received Avastin (bevacizumab). ... Merck announced that its pivotal phase 3 KEYNOTE-826 trial showed that Keytruda (pembrolizumab) plus chemotherapy with or without bevacizumab reduced the risk of death by
-
Merck’s Keytruda improves outcomes for metastatic cervical cancer patients
The phase 3 KEYNOTE-826 trial evaluated Keytruda (pembrolizumab) in combination with platinum-based chemotherapy with or without Roche’s Avastin (bevacizumab) for the first-line treatment of adults with persistent,
-
Roche’s diagnostic business sales offer a bright spot in Q4
treatments Herceptin (trastuzumab), Avastin (bevacizumab) and Rituxan (rituximab).
More from news
Approximately 21 fully matching, plus 191 partially matching documents found.
Latest Intelligence
-
Cancer immunotherapy: What's on the horizon?
Roche has already chalked up the first successes pairing Tecentriq (atezolizumab) with its veteran anticancer antibody Avastin (bevacizumab) in first-line NSCLC and kidney cancer, with additional trials of the duo
-
Stories that can save lives
Roche instituted similar principles in the promotion of its cancer drug, Avastin (bevacizumab), which works by finding and blocking the blood supply feeding malignant tumors.
-
Pharma deals in July 2015
Still in Japan, a week later AZ agreed a joint venture with Fujifilm Kyowa Kirin Biologics for the development and commercialisation of a biosimilar version of bevacizumab (Avastin) in phase I
-
Current development and marketing of biosimilar monoclonal antibodies in Latin America
NA. Bevacizumab. Biocad. Russia. BCD-021. Clinical. NSCLC: Ph III started in Oct 2012.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
October 2020: diversity and inclusion in clinical trials round-up
According to their study, Black patients were significantly less likely than white patients to show short-term visual improvement after being given bevacizumab (Avastin), a common treatment used in the
-
The Biosimilar Challenge
These include the infliximab biosimilars Inflectra and Remsima, the etanercept biosimilar Benepali (launched last year) and biosimilars to adalimumab, filgrastim and bevacizumab preparing to launch on the horizon.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
